注意喚起
現在、中国の一部で未知の感染症についてクラスタが発生しているという、つまり初期のコロナウイルスに似た事態が起こっていると言われていますが、
これについては私人等が正体不明のソースから発見報告したものでは全くない、WHO等による〈事実情報〉です— 八番空 (@AnneEmilReznik) November 25, 2023
まだ「この芽は悪い芽か、気にしすぎか」見守られている状態ですから、過剰に切迫した受け取り方・広め方は慎みましょう。ですが今後同じコースをたどる場合は、素早い水際対策（例えば国際便のストップ）など、国民レベルで理解が必要な行動を政府が取るべき段階があるわけで、
— 八番空 (@AnneEmilReznik) November 25, 2023
クラスターが発生しているとWHOのホームページにあるが大丈夫か？はっきりするまでとりあえず日本も渡航注意等出したらどうだ？https://t.co/BXnNUoeAvk
— ワールドウオッチ (@TasogareNippon) November 25, 2023
騒いだら負けの様な気もしないでもないー
— ℹ︎©︎hℹ︎ (@ichinisandaa) November 25, 2023
WHO statement on reported clusters of respiratory illness in children in northern China
22 November 2023 Statement Geneva, Switzerland Reading time: 1 min (342 words)WHO has made an official request to China for detailed information on an increase in respiratory illnesses and reported clusters of pneumonia in children.
At a press conference on 13 November 2023, Chinese authorities from the National Health Commission reported an increase in incidence of respiratory diseases in China. Chinese authorities attributed this increase to the lifting of COVID-19 restrictions and the circulation of known pathogens such as influenza, mycoplasma pneumoniae (a common bacterial infection which typically affects younger children), respiratory syncytial virus (RSV), and SARS-CoV-2 (the virus that causes COVID-19). Authorities stressed the need for enhanced disease surveillance in healthcare facilities and community settings, as well as strengthening the capacity of the health system to manage patients.
On 21 November, media and ProMED reported clusters of undiagnosed pneumonia in children in northern China. It is unclear if these are associated with the overall increase in respiratory infections previously reported by Chinese authorities, or separate events.
On 22 November, WHO requested additional epidemiologic and clinical information, as well as laboratory results from these reported clusters among children, through the International Health Regulations mechanism. We have also requested further information about recent trends in the circulation of known pathogens including influenza, SARS-CoV-2, RSV and mycoplasma pneumoniae, and the current burden on health care systems. WHO is also in contact with clinicians and scientists through our existing technical partnerships and networks in China.
Since mid-October, northern China has reported an increase in influenza-like illness compared to the same period in the previous three years. China has systems in place to capture information on trends in influenza, influenza-like illnesses, RSV and SARS-CoV-2, and reports to platforms such as the Global Influenza Surveillance and Response System.
While WHO seeks this additional information, we recommend that people in China follow measures to reduce the risk of respiratory illness, which include recommended vaccination; keeping distance from people who are ill; staying home when ill; getting tested and medical care as needed; wearing masks as appropriate; ensuring good ventilation; and regular hand-washing.
WHO will continue to provide updates.
WHOは中国に対し、呼吸器疾患の増加と小児の肺炎クラスターの報告に関する詳細な情報を公式に要請した。
11月21日、メディアとProMEDは、中国北部の小児で診断されていない肺炎の集団発生を報告した。これらが、中国当局が以前に報告した呼吸器感染症全体の増加と関連しているのか、それとも別の事象なのかは不明である。
11月22日、WHOは国際保健規則（International Health Regulations）メカニズムを通じて、報告された小児の集団感染に関する疫学的、臨床的情報および検査結果の追加提出を要請した。また、インフルエンザ、SARS-CoV-2、RSV、肺炎マイコプラズマを含む既知の病原体の循環における最近の傾向や、医療システムにおける現在の負担についても、さらなる情報を要請した。WHOはまた、中国における既存の技術提携やネットワークを通じて、臨床医や科学者とも連絡を取り合っている。
